You are here
- Home
- Drug Products
- All Drug Products
Open label, phase I ZD6474 head and neck cancer study (FDMA113 short study title).
- Disease
- solid tumour
- Drug Name
- Caprelsa
- Generic Name
- vandetanib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Dec 28, 2006
- Study Name
- D4200C00062
- Study Id
- D4200C00062
- ClinicalTrials.gov ID
- Recruiting Status
- Closed
- Report
-
Aug 30, 2012
- D4200C00062.pdf (189 KB)
